Authors
Jacqueline Palace, Romain Marignier, Aaron Abend, Simon A Broadley, Edgar Carnero Contentti, Tanuja Chitnis, Gabrielle deFiebre, Eoin P Flanagan, Massimo Filippi, Kazuo Fujihara, Lorna Galleguillos, Ruth Geraldes, Alejandra González, Benjamin Greenberg, Shahd Hamid, Jyh Yung Hor, Saif Huda, Ho Jin Kim, Ilya Kister, Julia Lefelar, Michael Levy, Silvia Messina, Andre Mochan, Ichiro Nakashima, Zoya Panahloo, Lekha Pandit, Stella Patsa, Aleksandra Podlecka-Piętowska, Sudarshini Ramanathan, Juan I Rojas, Eitzaz Sadiq, Jonathan D Santoro, Elias S Sotirchos, Silvia Tenembaum, De-Cai Tian, Fu-Dong Shi, Michael R Yeaman, Friedemann Paul
Published in
Multiple sclerosis (Houndmills, Basingstoke, England). Pages 13524585261500973. Nov 11, 2026. Epub Nov 11, 2026.
Abstract
Real-world data are crucial to improving care for patients with rare diseases.
To develop the first global map of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorders (NMOSD) patient registries/databases. Registries/databases were identified through rare disease portals, registry websites, and other sources, and surveyed.
Of the respondents (N = 26), the majority were established within the past 15 years and reported being self-funded. Most collect diagnostic, clinical, and laboratory data. Major objectives included supporting scientific research and advancing disease understanding.
Despite cost, time, resource, and data quality challenges, registries/databases provide important insights into addressing unmet needs in MOGAD and NMOSD.
PMID:
43016056
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0